Cost-Effectiveness Of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Compared With Efavirenz/Emtricitabine/Tenofovir As First-Line Hiv Antiretroviral Therapy In The Adult Population In The United States
Abstract
Authors
T. Juday T. Correll T. Bentley M. Broder